These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 16818928)

  • 1. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
    Del Brutto OH; Roos KL; Coffey CS; García HH
    Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial.
    Singh K; Saini AG; Khandelwal N; Singhi P
    J Child Neurol; 2022 Apr; 37(5):366-372. PubMed ID: 35213246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthelmintics for people with neurocysticercosis.
    Monk EJM; Abba K; Ranganathan LN
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD000215. PubMed ID: 34060667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating neurocysticercosis medically: a systematic review of randomized, controlled trials.
    Salinas R; Counsell C; Prasad K; Gelband H; Garner P
    Trop Med Int Health; 1999 Nov; 4(11):713-8. PubMed ID: 10588764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
    Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
    Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
    Kaur S; Singhi P; Singhi S; Khandelwal N
    Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
    Cárdenas G; Carrillo-Mezo R; Jung H; Sciutto E; Hernandez JL; Fleury A
    BMC Neurol; 2010 Mar; 10():16. PubMed ID: 20202200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
    Thussu A; Chattopadhyay A; Sawhney IM; Khandelwal N
    J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):272-5. PubMed ID: 17928325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthelmintics for people with neurocysticercosis.
    Abba K; Ramaratnam S; Ranganathan LN
    Cochrane Database Syst Rev; 2010 Jan; (1):CD000215. PubMed ID: 20091504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current approaches to cysticidal drug therapy for neurocysticercosis.
    Del Brutto OH
    Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure and radiological outcomes in children with solitary cysticercous granulomas with and without albendazole therapy: a retrospective case record analysis.
    Gulati S; Jain P; Sachan D; Chakrabarty B; Kumar A; Pandey RM; Gupta AK
    Epilepsy Res; 2014 Sep; 108(7):1212-20. PubMed ID: 24908563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial.
    Kalra V; Dua T; Kumar V
    J Pediatr; 2003 Jul; 143(1):111-4. PubMed ID: 12915835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthelmintics for people with neurocysticercosis.
    Abba K; Ramaratnam S; Ranganathan LN
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD000215. PubMed ID: 20238309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea.
    Kim SK; Wang KC; Paek SH; Hong KS; Cho BK
    Surg Neurol; 1999 Dec; 52(6):563-9. PubMed ID: 10660021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
    Matthaiou DK; Panos G; Adamidi ES; Falagas ME
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e194. PubMed ID: 18335068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial.
    Baranwal AK; Singhi PD; Khandelwal N; Singhi SC
    Pediatr Infect Dis J; 1998 Aug; 17(8):696-700. PubMed ID: 9726343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The course of seizures after treatment for cerebral cysticercosis.
    Vazquez V; Sotelo J
    N Engl J Med; 1992 Sep; 327(10):696-701. PubMed ID: 1495522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis.
    Cangalaya C; Zimic M; Marzal M; González AE; Guerra-Giraldez C; Mahanty S; Nash TE; García HH;
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004207. PubMed ID: 26658257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.